ArticleTargeted oncology2021

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib.

Nicola Fazio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.